timi天美传孟若羽

团队介绍：

王健副教授是timi天美传孟若羽介入血管外科的专家。他在该领域有丰富的经验和卓越的成就。其研究方向主要集中于各种良恶性肿瘤及肿瘤相关血管疾病的介入治疗。主要在肝癌、肺癌、盆腔肿瘤介入治疗领域有深入的研究。对于肝、肺肿瘤的消融、栓塞有丰富的治疗经验。对于门脉高压相关领域临床及基础研究亦为王健团队的重点研究方向。

其团队成员还包括吕天石副主任医师、宋莉副主任医师、佟小强主任医师、邹英华主任医师。研究方向为恶性肿瘤如原发性肝癌、转移性肝癌、肺癌、肾癌等肿瘤的微创介入治疗（栓塞、消融等）、门脉高压临床及基础研究。此外，其团队还包括若干名博士研究生及硕士研究生。

项目情况：

近五年来，主持并承担多项国家级及省部级科研项目，作为项目骨干主持参与科技部重点研发计划专项，为介入诊疗贡献团队智慧。

招生信息（拟招生的研究方向）：

放射影像学

科研项目：

1.&苍产蝉辫;在研临床试验：罢础颁贰联合阿替丽珠单抗+贝伐珠单抗对比单纯罢础颁贰治疗肝癌的研究；罢础颁贰联合阿仑伐替尼+础碍104对比罢础颁贰治疗肝癌的研究等；

2. 首发基金：基于CBCT动脉血流量化模型及MR高级成像技术建立早期肝癌精准、微创诊断研究等。

代表性研究成果：

近5年来，以第一作者、共同第一作者及通讯作者在专业领域期刊发表厂颁滨论文数十篇。

1. Cao S, Lyu T, Fan Z, Guan H, Song L, Tong X, Wang J, Zou Y. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance. Cancer Imaging. 2022 Jan 4;22(1):2. doi: 10.1186/s40644-021-00442-2.

2. Cao S, Zou Y, Lyu T, Fan Z, Guan H, Song L, Tong X, Wang J. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3?cm: emphasis on local tumor progression. Int J Hyperthermia. 2022;39(1):1-7. doi: 10.1080/02656736.2021.1998660.

3. Wang H, Wang J, Lv T, Cao S, Tong X, Song L, Zou Y. Loadability and Releasing Profiles In Vitro and Pharmacokinetics In Vivo of Vinorelbine and Raltitrexed by CalliSpheres Beads. Cancer Biother Radiopharm. 2023 Oct;38(8):536-542. doi: 10.1089/cbr.2019.3360.

4. Haochen W, Yinghua Z, Jian W. Intrahepatic arterial localizer guided transjugular intrahepatic portosystemic shunt placement: Feasibility, efficacy, and technical success assessed by a case series-a STROBE- compliant article. Medicine (Baltimore). 2019 Aug;98(33):e16868. doi: 10.1097/MD.0000000000016868.

5. Lyu T, Wang J, Cao S, Song L, Tong X, Zou Y. Radiofrequency ablation guided by cone beam computed tomography for hepatocellular carcinoma: a comparative study of clinical results with the conventional spiral computed tomography-guided procedure. J Int Med Res. 2019 Aug;47(8):3699-3708. doi: 10.1177/0300060519858010.

6. Haochen W, Jian W, Li S, Tianshi L, Xiaoqiang T, Yinghua Z. Combination of radiofrequency ablation and transcatheter arterial chemoembolization to treat hepatocellular carcinoma: measurement of distance from needle tip to nodule for assessment of local tumor progression. J Int Med Res. 2019 Jun;47(6):2516-2523. doi: 10.1177/0300060519844667.

7. Haochen W, Jian W, Li S, Tianshi L, Xiaoqiang T, Yinghua Z. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study. J Int Med Res. 2018 Jul;46(7):2650-2657. doi: 10.1177/0300060518768420.

8. Xie Y, Lyu T, Song L, Tong X, Wang J, Zou Y. Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension. J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101305. doi: 10.1016/j.jceh.2023.101305.

9.&苍产蝉辫;姚航,吕天石,武思彤等.肝细胞癌伴严重门静脉高压并发症行罢滨笔厂治疗的安全性摆闯闭.中国介入影像与治疗学,2023,20(08):463-466.顿翱滨:10.13929/箩.颈蝉蝉苍.1672-8475.2023.08.004.

10. 武思彤,吕天石,曹守金等.TIPS序贯TACE、靶向和/或免疫治疗BCLC D期原发性肝细胞癌伴严重门静脉高压并发症[J].中国介入影像与治疗学,2023,20(01):12-16.DOI:10.13929/j.issn.1672-8475.2023.01.003.

11. 江晴贵,吕天石,姚航,武思彤,宋莉,佟小强,李槐,邹英华,王健.肝细胞癌伴Vp4型门静脉瘤栓患者行挽救性TIPS的安全性及有效性研究[J].中华肝胆外科杂志,2023,29(10):727-731.DOI:10.3760/cma.j.cn113884-20230712-00198.